Current Chemicals Launches as Independent Specialty Materials Manufacturer, Building on 75-Year GE Legacy with Backing from Momentum Global VenturesFeb 2, 2026 11:04 AM Eastern Standard Time# Current Chemicals Launches as Independent Specialty Materials Manufacturer, Building on 75-Year GE Legacy with Backing from Momentum Global VenturesShare---CLEVELAND--([BUSINESS WIRE])--Today marks the debut of Current Chemicals, Inc. (CCI) as a fully independent U.S.-based specialty materials manufacturer. Backed by s ...

This audio is auto-generated. Please let us know if you have feedback Walmart and Target — two of the most prominent retailers in the U.S. — have new CEOs as of Sunday. Target’s former COO Michael Fiddelke has officially taken over the top spot from longtime CEO Brian Cornell, all while the Minnesota-based retailer has faced pressure to speak about U.S. government immigration activities in the state.“Stepping into this role is both humbling and deeply personal,” Fiddelke said in a company message Monday. “ ...

Freelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is putting a narrative to financial data. Working with teams that include senior editors, investment strategists, marketing managers, data analysts, and executives, I contribute ideas to help make content relevant, accessible, and measurable. Having ...

Ernest HoffmanErnest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations. Ernest began working in market news in 2007, establishing the broadcast division of CEP News in Montreal, Canada, where he developed the fastest web-based audio news service in the world and produced economic news videos in partnership with MSN and the TMX. He has a Bachelor's degree Specialization in ...

Freelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is putting a narrative to financial data. Working with teams that include senior editors, investment strategists, marketing managers, data analysts, and executives, I contribute ideas to help make content relevant, accessible, and measurable. Having ...

“We would like to make some home improvements to the tune of about $50,000 to $60,000.” (Photo subjects are models.) - Getty Images/iStockphoto Dear Quentin, My wife and I are retired. We are in our early 70s. We have close to $1 million in investment accounts, some in IRAs and some in regular accounts. We have $30,000 in an emergency fund. Our house is paid off. We live on Social Security and pensions. We would like to make home improvements to the tune of about $50,000 to $60,000. Should we take money ...

Core Viewpoint - Humana Inc. is experiencing stock price fluctuations and mixed signals from analysts and investors, indicating a complex outlook for the company in the health insurance sector [1][2][5]. Group 1: Analyst Insights - Morgan Stanley has set a price target of $174 for Humana, suggesting a potential decrease of approximately -10.86% from the current trading price of $195.20 [1][5]. - The stock has shown volatility, with a trading range today between $192.40 and $197.34, and over the past year, it has reached a high of $315.35 and a low of $191.39 [4]. Group 2: Investor Activity - Tejara Capital Ltd has acquired 7,200 shares of Humana, valued at around $1.87 million, indicating confidence in the company's long-term potential despite a slight decrease in stock price [2][5]. - Other hedge funds, such as Elevation Point Wealth Partners LLC and Mather Group LLC, have made new investments in Humana, with positions valued at approximately $32,000 and $34,000, respectively [3][5]. - Private Wealth Management Group LLC increased its holdings in Humana by 47.5% in the third quarter, now owning 149 shares valued at $39,000 [3]. Group 3: Market Metrics - Humana's market capitalization is approximately $23.48 billion, with a trading volume of 3,220,371 shares on the NYSE [4].

Palantir (PLTR) stock jumped 12% during premarket hours on Tuesday after posting fourth quarter earnings and revenue above Wall Street’s expectations on Monday, bolstered by sales to the Trump administration and US businesses. The company’s revenue surged 70% from the year-earlier period to $1.4 billion, ahead of the $1.3 billion expected by Wall Street analysts tracked by Bloomberg. Its adjusted earnings per share rose to $0.25 from $0.14 during the previous year, above the projected $0.23. Palantir’s f ...

Core Viewpoint - Palantir is expected to report strong fourth quarter earnings, with significant growth in both earnings per share and revenue, driven by robust sales to US businesses and government sectors [1][2][3]. Group 1: Earnings Expectations - Earnings per share are projected to increase to $0.23 from $0.14 year-over-year [1]. - Revenue is anticipated to surge over 60% to $1.3 billion [1]. Group 2: Revenue Breakdown - Revenue from commercial US sales is expected to rise nearly 124% year-over-year to $479 million [2]. - Sales to the US government are projected to account for approximately 40% of total revenue, with an expected contribution of $522 million, reflecting a nearly 52% increase from the previous year [3]. Group 3: Market Sentiment and Analyst Ratings - Despite strong earnings expectations, Palantir's stock has faced pressure due to concerns over valuation and broader market trends, with shares down over 10% in the past month [4]. - Analyst Louie DiPalma upgraded Palantir to Outperform, citing that the recent sell-off has made the valuation more reasonable compared to peers in the AI sector [5]. - The company's government contracts, despite controversy, are expected to contribute positively to the December quarter [6].

Amkor Technology (AMKR) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be releas ...